0HVB Stock Overview Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. More details
Rewards Risk Analysis 0HVB passed our risk checks.
See All Risk Checks Capture your thoughts, links and company narrative
Centene Corporation Competitors Price History & Performance
Summary of share price highs, lows and changes for Centene Historical stock prices Current Share Price US$60.14 52 Week High US$81.42 52 Week Low US$55.04 Beta 0.46 1 Month Change 0.71% 3 Month Change -19.69% 1 Year Change -18.73% 3 Year Change -26.55% 5 Year Change -2.85% Change since IPO 8.56%
Recent News & Updates
Director recently bought US$1.0m worth of stock Dec 20
Centene Corporation to Report Fiscal Year 2024 Results on Feb 04, 2025 Dec 16
Centene Corporation Provides Earnings Guidance for the Fiscal Year 2025 Dec 13
Executive VP & CFO recently bought US$1.0m worth of stock Nov 15
Centene Corporation Provides Earnings Guidance for the Year 2024 Oct 26
Third quarter 2024 earnings released: EPS: US$1.37 (vs US$0.87 in 3Q 2023) Oct 26 See more updates
Director recently bought US$1.0m worth of stock Dec 20
Centene Corporation to Report Fiscal Year 2024 Results on Feb 04, 2025 Dec 16
Centene Corporation Provides Earnings Guidance for the Fiscal Year 2025 Dec 13
Executive VP & CFO recently bought US$1.0m worth of stock Nov 15
Centene Corporation Provides Earnings Guidance for the Year 2024 Oct 26
Third quarter 2024 earnings released: EPS: US$1.37 (vs US$0.87 in 3Q 2023) Oct 26
Investor sentiment deteriorates as stock falls 16% Oct 22
Centene Corporation to Report Q3, 2024 Results on Oct 25, 2024 Oct 08
Ambetter Health of Delaware Offers Health Insurance in Delaware in 2025 Oct 04 Ambetter from Coordinated Care Offers Health Insurance Statewide in Washington in 2025
Centene Corporation Announces the Election of Thomas R. Greco to Board of Directors Aug 16
Second quarter 2024 earnings released: EPS: US$2.16 (vs US$1.93 in 2Q 2023) Jul 27
Centene Corporation to Report Q2, 2024 Results on Jul 26, 2024 Jul 04
Centene Corporation Updates Earnings Guidance for the Year 2024 Apr 27
First quarter 2024 earnings released: EPS: US$2.17 (vs US$2.05 in 1Q 2023) Apr 26
Centene Corporation, Annual General Meeting, May 14, 2024 Mar 30
Centene Corporation to Report Q1, 2024 Results on Apr 26, 2024 Mar 08
Full year 2023 earnings released: EPS: US$4.97 (vs US$2.09 in FY 2022) Feb 07
Centene Corporation Increases Premium and Service Revenues Guidance for the Fiscal Year 2024 Feb 06
Centene Corporation Announces Appointment of Michael A. Carson as President and Chief Executive Officer of Its Medicare Business Jan 23
Pure Health LLC completed the acquisition of Circle Health Group Limited from Centene Corporation (NYSE:CNC). Jan 13
Centene Corporation to Report Fiscal Year 2023 Results on Feb 06, 2024 Dec 13
Centene Corporation Provides Earnings Guidance for the Fiscal Year 2024 Dec 12
Centene Corporation Announces the Appointment of Susan Smith as Chief Operating Officer, Effective January 1, 2024 Nov 17
Third quarter 2023 earnings released: EPS: US$0.87 (vs US$1.29 in 3Q 2022) Oct 25
Centene Corporation Provides Earnings Guidance for the Full Year 2023 Oct 25
Centene Corporation Names Wade Rakes as Chief Growth Officer Oct 24
Centene Corporation to Report Q3, 2023 Results on Oct 24, 2023 Oct 05
Pure Health LLC agreed to acquire Circle Health Group Limited from Centene Corporation (NYSE:CNC) for an enterprise value of approximately $1.2 billion. Aug 29
Centene Corporation Provides Earnings Guidance for the Full Year 2023 Jul 29
Second quarter 2023 earnings released: EPS: US$1.93 (vs US$0.29 loss in 2Q 2022) Jul 28
Centene Corporation to Report Q2, 2023 Results on Jul 28, 2023 Jun 28
New Mountain Capital, L.L.C. acquired Apixio, Inc. from Centene Corporation. Jun 14
Centene Corporation Appoints T. Susko as Its Senior Vice President and Chief Communications Officer May 25
Centene Corporation Announces Resignation of James E. Murray as Chief Operating Officer May 23
New Mountain Capital, L.L.C. agreed to acquire Apixio, Inc. from Centene Corporation (NYSE : CNC). May 05
Centene to Divest AI Platform Apixio May 04
First quarter 2023 earnings released: EPS: US$2.05 (vs US$1.46 in 1Q 2022) Apr 26
CEO & Director recently bought US$1.9m worth of stock Mar 19
Independent Director recently bought US$503k worth of stock Feb 10
Centene Corporation Provides Earnings Guidance for the Full Year 2023 Feb 08
Full year 2022 earnings released: EPS: US$2.09 (vs US$2.31 in FY 2021) Feb 08
Centene Corporation to Report Fiscal Year 2022 Results on Feb 07, 2023 Dec 17
Centene Corporation Announces Management Changes Dec 16 Vivalto Santé SA completed the acquisition of Torrejon Salud, S.A. from Centene Corporation (NYSE:CNC).
Vivalto Santé SA completed the acquisition of Ribera Salud, S.A from Centene Corporation (NYSE:CNC). Nov 18
Centene Corporation Appoints Monte Ford to Board of Directors Nov 17
High number of new directors Nov 16
Centene Corporation Provides Earnings Guidance for the Full Year 2022 Oct 26
Centene Corporation to Report Q3, 2022 Results on Oct 25, 2022 Oct 06
Centene Corporation Appoints Ashlee Knuckey as Chief Ethics and Compliance Officer Sep 02
Centene Corporation Announces James Dallas to Step Down as Chairman of the Board Aug 02 Vivalto Sante Investissement entered into agreement to acquire Ribera Salud, S.A from Centene Corporation (NYSE:CNC) on July 25, 2022.
Vivalto Santé SA agreed to acquire SPANISH AND CENTRAL EUROPEAN BUSINESSES Of CENTENE from Centene Corporation (NYSE:CNC). Jul 26
A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC completed the acquisition of PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC). Jul 15
Centene Corporation to Report Q2, 2022 Results on Jul 26, 2022 Jul 01
Centene Corporation Revises Revenue Guidance for the Fiscal Year 2022 Jun 18
A consortium of The Vistria Group, LLC, General Atlantic Service Company, L.P. and Nautic Partners, LLC signed a definitive agreement to acquire PANTHERx Rare, LLC from Centene Corporation (NYSE:CNC). May 06
Independent Director recently bought US$507k worth of stock May 04
First quarter 2022 earnings released: EPS: US$1.46 (vs US$1.20 in 1Q 2021) Apr 27
High number of new directors Apr 27
Centene Corporation Provides Earnings Guidance for the Full Year 2022 Apr 27
Centene Corporation Announces Resignation of Leslie V. Norwalk, Esq. as A Member of the Board Apr 16 Centene Corporation Announces Executive Changes
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Feb 09
Centene Corporation Provides Earnings Guidance for the Full Year 2022 Feb 09
Centene Reportedly Drew Takeover Interest from Cigna in Recent Months Jan 28
Centene Corporation (NYSE:CNC) completed the acquisition of Magellan Health, Inc. (NasdaqGS:MGLN) from a group of shareholders. Jan 06
Centene Corporation Reaffirms earnings Guidance for 2021; Provides Earnings Guidance for 2022 Dec 11
Valtruis, Oak HC/FT Partners LLC, HLM Venture Partners and Founders of Rubicon completed the acquisition of an unknown majority stake in U.S. Medical Management, LLC from Centene Corporation (NYSE:CNC). Dec 08
Third quarter 2021 earnings released: EPS US$1.00 (vs US$0.98 in 3Q 2020) Oct 27
Independent Director David Steward has left the company Oct 12
Executive Vice President of HealthCare Enterprises Jeffrey Schwaneke has left the company Oct 03
Executive Vice President of HealthCare Enterprises Jeffrey Schwaneke has left the company Sep 29
Second quarter 2021 earnings released: US$0.92 loss per share (vs US$2.08 profit in 2Q 2020) Jul 28 Centene Corporation(NYSE:CNC) dropped from Russell 3000 Growth Index Shareholder Returns 0HVB GB Healthcare GB Market 7D -0.1% 0.2% 0.2% 1Y -18.7% -25.5% 2.3%
See full shareholder returns
Return vs Market: 0HVB underperformed the UK Market which returned 2.7% over the past year.
Price Volatility Is 0HVB's price volatile compared to industry and market? 0HVB volatility 0HVB Average Weekly Movement 5.1% Healthcare Industry Average Movement 4.5% Market Average Movement 4.7% 10% most volatile stocks in GB Market 10.4% 10% least volatile stocks in GB Market 2.6%
Stable Share Price: 0HVB has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0HVB's weekly volatility (5%) has been stable over the past year.
About the Company Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Show more Centene Corporation Fundamentals Summary How do Centene's earnings and revenue compare to its market cap? 0HVB fundamental statistics Market cap US$30.59b Earnings (TTM ) US$3.07b Revenue (TTM ) US$146.20b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 0HVB income statement (TTM ) Revenue US$146.20b Cost of Revenue US$124.53b Gross Profit US$21.67b Other Expenses US$18.61b Earnings US$3.07b
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 04, 2025
Earnings per share (EPS) 6.07 Gross Margin 14.82% Net Profit Margin 2.10% Debt/Equity Ratio 64.2%
How did 0HVB perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/30 04:35 End of Day Share Price 2024/12/30 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Centene Corporation is covered by 45 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution null null Argus Research Company Hua Ha Baird Ishan Majumdar Baptista Research
Show 42 more analysts 
